Advantage Alpha Capital Partners’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-20	Closed	-$285	–	192
2024 Q2	$285	Sell	20 -91,096	-100%	-$1.3M	﹤0.01%	154
2024 Q1	$1.29M	Sell	91,116 -14,021	-13%	-$199K	0.24%	90
2023 Q4	$1.59M	Buy	+105,137	New	+$1.59M	0.3%	87